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Abstract
Background: In response to concerns that the needs of the aging population for well-integrated care were increasing, the English National 
Health Service (NHS) appointed 16 Integrated Care Pilots following a national competition. The pilots have a range of aims including 
development of new organisational structures to support integration, changes in staff roles, reducing unscheduled emergency hospital 
admissions, reduced length of hospital stay, increasing patient satisfaction, and reducing cost. This paper describes the evaluation of the 
initiative which has been commissioned.
Study design and data collection methods: A mixed methods approach has been adopted including interviews with staff and patients, 
non-participant observation of meetings, structured written feedback from sites, questionnaires to patients and staff, and analysis of rou-
tinely collected hospital utilisation data for patients/service users. The qualitative analysis aims to identify the approaches taken to integra-
tion by the sites, the benefits which result, the context in which benefits have resulted, and the mechanisms by which they occur.
Methods of analysis: The quantitative analysis adopts a ‘difference in differences’ approach comparing health care utilisation before 
and after the intervention with risk-matched controls. The qualitative data analysis adopts a ‘theory of change’ approach in which we 
triangulate data from the quantitative analysis with qualitative data in order to describe causal effects (what happens when an independent 
variable changes) and causal mechanisms (what connects causes to their effects). An economic analysis will identify what incremental 
resources are required to make integration succeed and how they can be combined efficiently to produce better outcomes for patients.
Conclusion: This evaluation will produce a portfolio of evidence aimed at strengthening the evidence base for integrated care, and in par-
ticular identifying the context in which interventions are likely to be effective. These data will support a series of evaluation judgements 
aimed at reducing uncertainties about the role of integrated care in improving the efficient and effective delivery of healthcare.
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Background
There are growing numbers of people with chronic con-
ditions with a particularly rapid rise in the number with 
multiple care needs. The complex needs of people with 
multiple chronic conditions require the development of 
delivery systems that bring together a range of profes-
sionals and skills from both the cure and care sectors 
to meet those needs. Despite this, service delivery has 
developed in ways that have tended to fragment care, 
both within and between sectors, through for example 
structural and financial barriers dividing providers at the 
primary/secondary care and at the health and social 
care interface; distinct organizational and professional 
cultures; and differences in terms of governance and 
accountability [1].
A substantial number of evaluations have been carried 
out of interventions designed to improve the integra-
tion or coordination of care. A systematic review based 
on 21 reviews and 85 primary studies [2] showed that 
many  of  these  initiatives  were  effective  in  improv-
ing care, though many fewer resulted in a reduction 
in healthcare costs (Table 1). One of the conclusions 
of this and other reviews is that the effectiveness of 
attempts  to  provide  better  integrated  care  is  highly 
dependent  on  the  context  in  which  the  intervention 
takes place. Interventions cannot be seen separated 
from the context in which they are introduced, and this 
has been an important guiding principle in the evalua-
tion described in this paper.
In response to concerns that the needs of the aging 
population  for  well-integrated  care  were  increasing, 
the UK Department of Health for England announced 
in 2008 that a number of ‘Integrated Care Pilots’ would 
be  established.  Healthcare  purchasers  and  provid-
ers  were  invited  to  submit  proposals  for  innovative 
approaches  to  providing  better  integrated  care  [3]. 
There was no specification as to the form that such 
integration should take, or client groups who should 
receive the intervention. There were over 100 appli-
cations, and after a two-stage selection process, the 
Department of Health selected 16 pilots. The locali-
ties of selected pilots and the main focus of each are 
described in Annex 1.
Table 1. Summary of the evidence on the effectiveness of interventions to improve coordination in health care, from Powell Davies et al. [2]
Main focus of intervention Proportion (%) 
of studies with 
positive outcome 
for health
Proportion (%) of 
studies with positive 
outcome for health/
social care service 
user satisfaction
Proportion 
(%) of studies 
with positive 
outcome for cost 
saving
Changed relationships between service providers  
Structured relationships between service providers 
including co-location, case management, multi-disciplinary 
teams or assigning health/social care service users to a 
particular PHC provider (33 studies)
19/29 (65.5%) 8/12 (66.7%) 2/12 (16.7%)
Coordination of clinical activities  
Using structured arrangements for coordinating service 
provision between providers, including joint consultations, 
shared assessments and priority access to another clinical 
service (37 studies)
19/31 (61.3%) 4/12 (33.3%) 3/15 (20%)
Improving communication between service providers  
Interventions designed to improve communication between 
service providers, e.g. case conferences (56 studies)
26/47 (55.3%) 12/22 (54.5%) 2/21 (14.3%)
Support for clinicians 
Interventions include support or supervision for clinicians, 
training (joint or relating to collaboration), and reminder 
systems (33 studies)
16/28 (57.1%) 8/14 (57.1%) 1/12 (8.3%)
Information systems to support co-ordination 
Using information systems to support the coordination of 
care, including care plans; decision support, proformas; 
health/social care service user held or shared records; 
shared information or communication systems; and a 
register of health/social care service users (47 studies)
23/38 (60.5%) 7/19 (36.8%) 2/13 (15.4%)
Support for health/social care service users 
Interventions include education, reminders and assistance 
in accessing care (19 studies)
6/17 (35.3%) 3/6 (50.0%) 1/7 (14.3%)
All studies 36/65 (55.4%) 14/31 (45.2%) 5/28 (17.9%)International Journal of Integrated Care  – Vol. 10, 27 September 2010 – ISSN 1568-4156  – http://www.ijic.org/
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A team from RAND Europe, Ernst and Young LLP and 
the University of Cambridge were appointed to carry 
out  a  three-year  evaluation  that  was  augmented  by 
the inclusion in the evaluation of experts from the Nuf-
field Trust. The evaluation aims to answer the following 
questions:
What  approaches  to  integration  have  been  • •
employed by the pilots?
What approaches to integration work well and in  • •
what contexts?
Who benefits from integration, in what ways, and  • •
with what consequences for equity?
What resources are required to make integration  • •
succeed and how can these be efficiently used?
In delivering integrated care in the English National  • •
Health  Service,  what  policies  and  practices  are: 
most likely to deliver the intended outcome, most 
capable  of  being  implemented  and  most  accept-
able  to  patients,  users,  clinicians,  managers  and 
the wider public.
A  mixed  methods  approach  was  adopted  includ-
ing interviews with staff and patients, non-participant 
observation of meetings, structured written feedback 
from sites, questionnaires to service users and staff, 
and analysis of routinely collected hospital utilisation 
data for patients/users who had been recruited into the 
pilots.
Analytical framework
Our approach to understanding the context in which 
integration  takes  place  is  based  on  two  classifica-
tions relating to structure and function. At the start of 
the evaluation these classifications were deliberately 
general to avoid focusing too early on very specific 
approaches to integrated care. We wanted to accom-
modate the fact that that the pilots themselves were 
still refining their approaches.
a) Structure
Integration can be seen as occurring at three levels 
[4, 5]
• • Micro-level  integration  activities.  These  promote 
integration  among  individual  practitioners  within 
a  single  organisation  (e.g.  between  doctors  and 
nurses in a primary care practice setting).
• • Meso-level  integration  activities.  These  promote 
integration among practitioners working in different 
organisations (e.g. between GPs and specialists). 
This  might  include  co-location  of  services,  which 
could occur with or without macro-level activities, 
such as pooled budgets.
• • Macro-level  integration  activities.  These  promote 
integration  designed  to  facilitate  organisation-to- 
organisation working, e.g. across different sectors. 
These may include policy agreements and finan-
cial arrangements. Examples of these are pooled 
budgets or joint budget holding between health and 
social care services, employment of care staff in a 
single organisation, or structural changes to facili-
tate work across two or more organisations.
b) Function
Integration can be classified [6] in terms of
• • Organisational  integration,  where  organisations 
are brought together by mergers or by structural 
change.
• • Service integration, where different clinical services 
or support/back-office functions are integrated.
• • Clinical integration, where the focus is on care for a 
particular condition.
This classification will guide our analysis of the data, 
and our testing of the various hypotheses which arose 
during the course of the study. These included hypothe-
ses that integrated care would lead to the development 
of new organisational structures to support integration, 
changes in staff roles, increased staff job satisfaction, 
fewer  unscheduled  emergency  hospital  admissions, 
reduced length of hospital stay, increased patient sat-
isfaction, and reduced cost.
It should be noted that the evaluation was designed and 
funded prior to the appointment of the integrated care 
pilots, so these hypotheses were developed during the 
first six months of the evaluation as a result of detailed 
interaction with the sites. This unusual research design 
allowed for the evaluation to be tailored to the aims of 
the sites which were not known at the time the evalua-
tion team was appointed.
Research methods
Principles guiding the evaluation
The evaluation described here adopts the approach 
of  the  ‘embedded  evaluator’.  The  evaluation  activi-
ties form a distinct strand within the Integrated Care 
Pilot programme, helping to co-produce the successful 
delivery of the programme, rather than a completely 
separate study focused solely on contributing to the 
scientific understanding of integrated care. However, 
it is equally important that the evaluation contributes 
to scientific understanding and that it generates valid 
and independent evidence to support decision-making 
in the future. The approach combines systematically 
collecting and synthesizing evidence from across all 
the  pilots  together  with  a  deeper  investigation  of  a 
smaller number of pilots in order to gain more detailed This article is published in a peer reviewed section of the International Journal of Integrated Care   4
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understanding of the structures, processes, costs and 
outcomes of integration.
Integrated Care Pilots use a variety of integrating activ-
ities  (ranging  from  influencing,  creating  incentives, 
sharing information, creating new information systems 
and so forth) and have a variety of objectives (including 
improving the effectiveness and efficiency of services, 
enhancing patient reported outcomes and delivering 
measurable health improvements. In this context, the 
research approach is multi-method in order to under-
stand both the activities pursued and the outcomes 
achieved. The evaluation is based on six approaches 
to data collection and analysis:
Systematic qualitative data collection from all sites  1. 
(through a ‘Living Document’ which is a semi-struc-
tured document completed regularly by each pilot 
site).
In-depth  case  studies  of  six  sites  (‘Deep  Dives’)  2. 
including interviews with staff and patients/service 
users and non-participant observation of meetings 
[see Section Systematic qualitative data collection 
from all sites (the ‘Living Document’) for more on 
why we decided to use case studies].
Difference in differences analysis of data on hos- 3. 
pital  utilization  comparing  patients/service  users 
enrolled in pilots with control data.
Data from patient questionnaires. 4. 
Data from staff questionnaires. 5. 
Analysis of costs (combining data from qualitative  6. 
case studies and quantitative data on service uti-
lization).
Evaluation involves a number of activities leading to an 
exercise of judgement [7, 8]. In evaluating the complex 
set of activities which broadly sit under the heading of 
‘Integrated Care Pilots’ we also seek to arrive at judge-
ments which are seen to be legitimate by the stakehold-
ers involved [9]. This requirement for legitimacy is one 
of the many ways in which ‘pure’ research is distinct 
from  evaluation.  This  legitimacy  potentially  involves 
five steps (similar to those identified by Scriven [10]):
Understand  from  those  delivering  the  pilots  and  1. 
from  those  funding  the  initiative  the  criteria  they 
consider to be applicable.
Agree the standards and intended outcomes that  2. 
are applicable.
Gather data relating to these standards and out- 3. 
comes.
Assess  the  contribution  made  by  the  agency/  4. 
activity in achieving these standards and outcomes.
Form a performance audit judgement. 5. 
These steps protect the evaluators from the accusa-
tion of being arbitrary or otherwise non-rational, but 
an important part of the logic of the evaluation is to 
develop a set of hypotheses based on the ‘theory of 
change’ offered up by the pilots themselves. Implicitly 
or explicitly, many evaluations of complex interventions 
use a ‘theory of change’ approach. These evaluations 
aim not only to understand the contribution made by a 
programme or activity to achieving outcomes, but also 
to interrogate evidence and communicate findings to 
support both learning and accountability. Our approach 
takes as its starting point the argument of Weiss [11, 
p. 66–67] that: “The concept of grounding evaluation 
in theories of change takes for granted that social pro-
grammes are based on explicit or implicit theories about 
how and why the programme will work…The evalua-
tion should surface those theories and lay them out in 
as fine detail as possible, identifying all the assump-
tions and sub-assumptions built into the programme. 
The evaluators then construct methods for data collec-
tion and analysis to track the unfolding assumptions. 
The aim is to examine the extent to which programme 
theories  hold…the  evaluation  should  show  which  of 
the assumptions underlying the programme are best 
supported by the evidence.”
In this sense, ‘theories of change’ is a guiding approach 
rather than a methodology, and its successful delivery 
requires harnessing a range of methodologies, such 
as those outlined elsewhere in this paper. Our ‘theo-
ries of change’ approach has five precepts. First the 
approach requires us to not only look at the outcomes 
of the programme but to pay equal attention to pro-
cesses.  This  contrasts  with  more  classical  evalua-
tion approaches which tend to look at outcomes first 
and then to look for evidence to support attribution. 
Secondly, the approach requires a more ‘embedded’ 
evaluator where the evaluator works closely with policy 
makers, practitioners and end users to understand and 
elaborate  a  sometimes  changing  theory  of  change. 
Without losing their independence, successful evalu-
ators will understand the world of the policy makers, 
practitioners  and  service  users,  including  an  under-
standing of what motivates their behaviour. Thirdly, the 
approach requires an ability to reconstruct and rep-
resent the sequence of events connecting actions to 
each other and how these contributed to the outcomes 
identified,  reconstructing  at  least  the  sequence  of 
events and statistical co-variations, but preferably also 
identifying the causal mechanisms at work. Fourthly, 
the approach is sensitive to the possibility that during 
the life of a programme or intervention, initial theories 
of change may alter in response to learning or to exog-
enous events and that the evaluation needs to capture 
these changing understandings and actions. Fifthly, it 
will also be sensitive to the fact that different and poten-
tially conflicting theories of change might be simultane-
ously pursued within any one programme. Collectively, 
these precepts describe an interest not only in causal International Journal of Integrated Care  – Vol. 10, 27 September 2010 – ISSN 1568-4156  – http://www.ijic.org/
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effects (what happens when an independent variable 
changes) but also causal mechanisms (what connects 
causes to their effects); not only what officials say they 
do but what the evidence shows they do; and not only 
what contribution stories practitioners tell themselves 
and others but also what really contributes to benefit. 
Therefore, theory building and testing is an important 
part of the approach taken but it does not start with a 
priori theoretical claims or assumptions.
Systematic qualitative data collection 
from all sites (the ‘Living Document’)
The  Living  Document  involves  semi-structured  data 
collection from all Integrated Care Pilots at approxi-
mately  six-monthly  intervals  during  the  evaluation. 
A  lead  person  is  designated  in  each  site  to  collate 
responses in the Living Document, but in most cases, 
this individual draws on a variety of sources in collating 
responses, and there is an expectation that the views 
of a wide range of stakeholders will be represented in 
the completion of the document. The data collected 
in the Living Document are organised into a series of 
broad questions:
Development of the pilot and background informa- • •
tion. Questions identifying the background, purpose 
and background setting of the pilot.
Who  is  doing  what?  Identifying  the  main  people  • •
and organisations involved, and their roles in imple-
menting the pilot.
Processes—identifying  the  intended  processes,  • •
and processes which have been implemented so 
far.
Outputs and outcomes achieved so far. • •
Progress to date. A description of progress to date,  • •
an assessment of progress against plan, and an 
outline of what has facilitated/prevented progress.
Sustainability. Assessment of how arrangements to  • •
promote sustainability are progressing.
Attribution of changes to specific initiatives relating  • •
to the pilot. An assessment of how much difference 
is really being made by the pilot itself, in the context 
of  other  health  policy  initiatives  which  are  taking 
place concurrently.
Resource implications of the pilot. Without attempt- • •
ing to provide a precise monetary value to the out-
comes of the pilot, an assessment of the costs of 
the  pilot,  and  whether  benefits  might  have  been 
achieved more easily in other ways.
After each round of data collection, data from the Liv-
ing  Document  are  analysed,  and  feedback  is  given 
in two ways. First, limited feedback is given to each 
site, including the opportunity to specify where more 
detailed  information  is  needed  in  future  rounds  of   
Living  Document  completion.  Second,  the  overall 
themes emerging from the Living Document are analy-
sed, and these are fed back in a single document to all 
sites after each round of data collection. This analysis 
also contributes to ‘learning events’ (conferences and 
teleconferences  to  address  different  issues  of  rele-
vance to pilots) which are being run by the Department 
of Health throughout the pilot period, and subsequent 
rounds of the Living Document are adapted in light of 
feedback from the sites.
In-depth case studies of six sites 
(‘Deep Dives’)
We selected a range of types of pilots for in-depth case 
study to reflect the range of approaches in the pilots 
and then select a sample from these reflecting the need 
for variety and site’s ability to support a more detailed 
evaluation. For the depth case studies in six sites, we 
will  structure  the  evaluation  using  an  approach  that 
combines logic modeling with process mapping of the 
patient journey. These methods will complement each 
other in creating a full picture of the integration path-
ways. Logic models [12] provide a brief summary of 
the key elements of an intervention (or programme, or 
project) and organize inputs, processes, outputs and 
outcomes systematically. They facilitate a focus on the 
causal links in the chain connecting the allocation of 
resources to the intended outcomes. As such, they are 
well suited to supporting an understanding the ‘theory 
of  change’  underpinning  the  activity  and  simultane-
ously identifying the sorts of data that might support or 
weaken that theory [11].
This approach will provide both a way to describe and 
communicate  the  different  interventions  but  also  to   
provide a basis for what, causally, is happening. It will 
provide the framework for understanding how the inputs 
of a pilot are related to its outcomes and impacts. They 
are especially helpful in developing a shared under-
standing of a process between stakeholders and serve 
as a reference point for stakeholders in the initiative 
or  programme.  Process  mapping  the  service  user 
experience,  by  contrast,  involves  understanding  the 
motivations, experiences and outcomes of the various 
interactions between the service user and the (inte-
grated) service [13].
Using these case studies, we will address the following 
questions:
What approaches to integration have been employed  • •
by the pilots? This will provide a richer description 
of models than is possible in the overall national 
evaluation by exploring experiences, motivations, 
relationships, processes and costs in more detail.This article is published in a peer reviewed section of the International Journal of Integrated Care   6
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conditions  (see  Annex  2),  and  length  of  stay.  We 
derived the list of ambulatory sensitive conditions from 
AHRQ [14] and Purdy et al. [15].
Information will be available for the individuals enrolled 
in any intervention, and also for the whole populations 
of general practices which are participating in the Inte-
grated Care Pilot. The data will be at person level but 
anonymised so that the research team cannot identify 
sensitive personal information or individual identities. 
The  NHS  Information  Centre  for  Health  and  Social 
Care will act a trusted third party to handle any confi-
dential information and create the anonymised linked 
fields for use by the research team.
One of the key challenges in undertaking analyses of 
changes in hospital use for complex interventions is 
that  individuals  may  be  selected  for  an  intervention 
because they have a high use of health services. The 
problem is that any subsequent fall in utilisation in this 
group may simply be due to regression to the mean— 
that is people reverting to a normal level of use irre-
spective of the intervention. One way round this is to 
use an approach that allows us to standardise for dif-
ferences in the risk of future admissions.
First, we will assess the impact of the intervention on 
individuals enrolled in the Integrated Care Pilots. Infor-
mation on the prior patterns of diagnoses and hospital 
utilisation will be used to stratify cases according to the 
risk of admission. The actual level of utilisation before 
and after the agreed starting point in each pilot will be 
compared. In this way we will be able to track levels of 
hospital use for cohorts of people for 2–3 years before 
they became part of the pilot. We will then test for sub-
sequent change and compare results by risk strata.
In  addition,  we  will  undertake  a  more  sophisticated 
analysis  to  create  a  matched  ‘control  group’  con-
structed by identifying individuals within national data. 
These control cases will be matched on a number of 
variables including risk of admission (or other hospital 
use); major diseases recorded; history of hospital use; 
and characteristics of the area of residence, such as 
levels of deprivation. Matching will be conducted using 
propensity  scoring  techniques  [16]  and  prognostic 
scoring techniques [17]. Trends in hospital use within 
the groups of selected control cases will then be used 
as a test of observed differences in those enrolled in 
the Integrated Care Pilots.
Second, we will quantify the effect of the interventions 
on wider groups of patients (e.g. practice populations) 
by matching utilization data to that from to similar prac-
tice populations in national HES datasets. The popula-
tion level analysis will assess whether the intervention 
might not only have an impact on individual patients 
but also upon the wider population.
What approaches to integration work well and in  • •
what contexts? This will generate data linking puta-
tive causes to observed effects i.e. understanding 
causal mechanisms.
Who  benefits  from  integration  and  in  what  ways  • •
(what definitions are there of ‘success’)? This will 
identify how benefits are distributed and with what 
implications for equality.
What resources are required to make integration  • •
succeed and how can these be efficiently used? 
This will identify the descriptive categories of costs, 
establishing  their  dimensions,  estimating  overall 
costs,  and  suggesting  how  generalisable  these 
findings might be. The Living Document will help 
identify  what  types  of  costs  become  apparent  at 
various stages of development of a project.
How the development of integrated care is facilitated  • •
or impeded by other current policies, e.g. payment 
by results, practice-based commissioning etc.
From these analyses, we aim to identify what policies 
and practices are most suitable (i.e. fit for purpose and 
likely to deliver the intended outcome); most feasible 
(i.e. capable of being implemented given the existing 
architecture of delivery and accountability); and most 
acceptable (i.e. likely to generate the support of the 
people who use services, clinicians and other profes-
sionals, managers and the wider public).
There will be three key data collection methods: semi-
structured interviews with professionals and patients/
service users, documentary analysis, non-participant 
observation of meetings. The qualitative data collec-
tion in the Deep Dive sites will also be used to collect 
data for the economic analysis (see below).
Interviews with staff will concentrate on the experience 
of delivering care, interactions with other professional 
groups  and  organizations  within  the  Integrated  Care 
Pilot, and understanding of implications for the wider 
care  system.  Interviews  with  patients  and  users  will 
focus on the patient/user journey and experience and 
its relationship to changes in the Integrated Care Pilots.
Service utilisation
In analysing data on service utilisation, we will focus 
principally on hospital admissions as a key variable, 
as many of the sites have a focus on reducing such 
admissions.
Data  will  be  taken  from  Hospital  Episode  Statistics 
(HES),  both  for  outpatient  referrals,  accident  and 
emergency attendances and inpatient stays. These will 
enable analyses of changes in a number of measures 
of hospital use including overall rates of emergency 
admissions,  admissions  for  ‘ambulatory  sensitive’  International Journal of Integrated Care  – Vol. 10, 27 September 2010 – ISSN 1568-4156  – http://www.ijic.org/
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both  observed  differences  between  intervention  and 
control groups as well controlling for unobserved but 
fixed person characteristics.
The aim of identifying risk-matched controls and using 
propensity score analysis is to allow so far as possible 
for unmeasured patient and system effects and there-
fore to increase our ability to draw conclusions about 
likely cause and effect from what inevitably remains 
observational data.
Questionnaires for service users
We are conducting two surveys to assess the experi-
ence of service users in 11 of the 16 pilots. The survey 
is being administered in autumn/winter 2009 and will 
be repeated on the same sample of service users in 
autumn 2010. The questionnaire was developed using 
the intended outcomes identified by pilot sites in their 
applications to join the scheme. This identified a num-
ber of domains which were common to most pilots and 
were therefore included in the questionnaire. These 
were:
Communication  with  primary  care  doctors  and  • •
nurses.
Organisation and coordination of care. • •
Care planning. • •
Assessment of care from social services. • •
Arrangements following discharge from hospital. • •
Frequency of certain critical events (notes unavail- • •
able, test duplicated, wrong medication or wrong 
dose  of  medication  prescribed,  no  follow-up 
arrangements after hospital discharge).
In addition, a question on service usage was included 
to  contribute  to  the  analysis  of  health  service  costs 
(see below). The questionnaire is available from the 
authors.
In  selecting  items  to  represent  these  domains,  we 
drew questions were possible from existing validated 
instruments. In particular we drew a substantial num-
ber of questions from the English National GP patient 
survey which is currently sent annually to 5.5 million 
randomly  sampled  patients  (www.gp-patient.co.uk). 
By matching the socio-demographic and health ques-
tions to this survey also, we will be able to conduct a 
difference in differences analysis with individual con-
trol  patients  drawn  from  responders  to  the  national 
survey.
For  five  pilot  sites  it  was  not  appropriate  to  collect 
patient information using this questionnaire because 
of the nature of the intervention and/or the population 
group targeted by the intervention (for example, some 
pilots were focusing on end of life care). These sites 
are excluded from this part of the evaluation.
Both of these approaches to analysis are required as 
there might be an impact of the interventions on indi-
viduals (e.g. a reduction in admissions) which could not 
be demonstrated in the wider population. This might be 
because resources were simply redistributed between 
groups at equal risk of admission, or because the num-
bers enrolled in the pilots were too small to show an 
effect on the wider population.
Sample size calculations suggest that few of the Inte-
grated Care Pilot sites will enroll sufficient numbers for 
data from individual sites to be analysed. We therefore 
intend to pool data from sites which have similar aims 
and are providing broadly comparable interventions. 
It is not possible to say which sites will provide data 
that can be pooled, as all sites are still developing their 
interventions. However, it looks likely, for example, that 
several sites will be using a form of case management 
of high-risk patients with the aim of reducing hospital 
admission, and we will be able to pool data from such 
sites. Data will also be analysed on primary and social 
care utilisation (from patient questionnaires). However, 
these data are being collected primarily for the eco-
nomic analysis, as none of the sites has reduction in 
primary care utilisation as their main goal.
Our  analysis  strategy  is  built  around  a  generalized 
difference-of-differences  regression  approach  at  the 
person level. Regression models appropriate for each 
of  the  outcome  measures  (e.g.  emergency  admis-
sions) will be developed. These may be Poisson mod-
els, negative binomial models, or gamma models as 
required by the form of the measure. Each individual 
will contribute one or more time periods to the data-
set  in  both  the  pre-  and  post-intervention  periods. 
Non-intervention controls will come from routinely col-
lected national data. These models will use covariates 
including basic demographics and historical utilization 
to control for potential differences between the inter-
vention and control cases. Person level random effects 
will also be included in the models to adjust standard 
errors for the repeated measures within person.
In addition to the traditional covariate adjustment in 
the  difference-of-differences  model  we  will  use  pro-
pensity score based methods. In a combined dataset 
of intervention cases and non-intervention controls a 
propensity score model will be fitted that uses avail-
able covariates to predict intervention vs. control sta-
tus. The predicted treatment status probabilities can 
be  used  to  match  intervention  and  control  cases. 
We may also use the propensity scores to produce 
analysis weights which can be combined with cova-
riate adjustment to support ‘doubly robust’ estimation 
of intervention effects [18]. Doubly robust estimation 
combined with difference-of-differences modeling will 
provide  intervention  effect  estimates  that  control  for This article is published in a peer reviewed section of the International Journal of Integrated Care   8
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Care Pilots. This will provide a sense of how much 
the approach might cost if it were implemented else-
where. An important part of this will be through data 
collection in the Deep Dive sites where we will use the 
logic model, process maps, key informant interviews, 
and  documentary  evidence  to  produce  estimates  of 
the costs of providing integrated care. This will enable 
us to identify the categories of cost and the scale of 
resources required to deliver different models of inte-
gration. We aim to produce a clear understanding of 
the main categories of cost (staff by grade, equipment, 
building, travel etc.), the likely range of costs within 
each category, and subsequently estimate best, worst 
and most likely case scenarios.
We will also distinguish between ‘set-up’ costs and ‘run-
ning costs’, although in a fluid, adaptive and improving 
system it may be difficult to draw this distinction. For 
both of these we need to distinguish between the costs 
associated  with  participating  in  the  DH  programme 
(including, for example, participation in events, report-
ing,  contributing  to  the  national  evaluation)  and  the 
costs solely required to deliver the integrated care pro-
gramme. We also aim to gather data through time that 
can show how costs have altered in response to actual 
service  delivery  or  in  order  to  overcome  changing 
circumstances etc. We propose only to look at costs 
internal to the health and social care system (including 
private sector partners) but we will be aware that costs 
could  potentially  be  externalised  onto  service  users 
and carers and we will ask service users and staff to 
comment on their sense of the types and magnitudes 
of these costs.
Across the Integrated Care Pilots where we are col-
lecting quantitative data on hospital utilisation, data on 
hospital admissions and length of stay will be costed 
using standard NHS costs, and included in the con-
trolled difference in differences analysis described in 
above.
Conclusion
Selecting  evaluation  frameworks  always  involves  a 
degree  of  compromise  to  meet  conflicting  demands 
within a finite budget. We have opted to balance the 
collection of data from across all the pilots with more 
detailed data from six Deep Dive sites. We have also 
opted to focus the evaluation on what the pilots them-
selves told us they were seeking to achieve. The ben-
efit of this is that we will be in a position to provide 
an  evaluation  which  is  grounded  firmly  in  what  the 
pilots are seeking to do. This increases the chances 
that findings will be acceptable and used. However, 
it also means that some theoretical propositions will 
be under-explored and that attention may be directed 
Questionnaires  are  being  sent  to  up  to  500  service 
users in each site. Where the site has identified more 
that  500  service  users  by  autumn  2009,  a  random 
sample of 500 will be taken. Where fewer than 500 
service users have been identified by March 2010, the 
questionnaire is sent to them all. Where a site is enroll-
ing patients/service users sequentially during autumn 
2009/spring 2010, all patients receive a questionnaire 
until 500 have been enrolled. Those individuals who 
receive a questionnaire in autumn 2009/spring 2010 
will receive a second questionnaire in autumn 2010. 
For all service users, the site identifies the start data 
of any intervention, so that we can determine whether 
questionnaires returned have been completed before 
or after the start of the intervention.
Questionnaires for health and social 
care staff
We are conducting two cross-sectional staff surveys 
within  the  16  pilot  sites,  involving  health  and  social 
care  staff  (including  community  nurses,  GPs  and 
social workers), in spring 2010, and repeated in spring 
2011. The staff questionnaire has substantial sections 
for free text to allow staff to describe their experience 
of the pilot in more detail, and these sections will be 
transcribed for qualitative analysis. The questionnaire 
includes sections on:
Job changes since the introduction of the Integrated  • •
Care Pilot.
Perceived changes to the care that patients/service  • •
users receive.
Changes  in  communication  within  and  between  • •
employing organisations.
Changes in team working. • •
Communication with other health and social care  • •
staff.
Job satisfaction, ability to deliver high quality care. • •
For  the  staff  survey  the  targeted  sample  size  is  50 
staff from each site. The first are staffs who are closely 
involved in the development of the pilot (e.g. employed 
by the pilot). There are expected to be between 5 and 
15 of these per site. The additional 35–45 will be sent 
to  stratified  random  samples  of  practitioners  whose 
work might be altered by the pilot—e.g. GPs, commu-
nity nurses, social workers.
Economic analysis
There are two approaches to the economic evalua-
tion. The first is to estimate costs in order to provide 
decision-makers in the health and social care systems 
with  a  basis  for  understanding  the  categories  and 
potential range of costs associated with the Integrated International Journal of Integrated Care  – Vol. 10, 27 September 2010 – ISSN 1568-4156  – http://www.ijic.org/
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evidence  base  for  integrated  care,  and  in  particular 
identifying the context in which interventions are likely 
to be effective. These data will support a series of eval-
uation judgements but it is important to recognise that 
they cannot be arrived at by simple aggregation of data 
[20]. Rather, the process locates the new data within 
the existing body of research and forms judgements 
about what is added and how compelling this addi-
tional evidence is, thus reducing uncertainties about 
the role of integrated care in improving the efficient and 
effective delivery of healthcare.
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more  towards  intended  outcomes  than  unintended 
outcomes. However, we are satisfied that this risk is 
managed by independent data collection (for example 
on service utilisation, service user surveys and staff 
surveys) and by the iterative way of working with those 
responsible for running each project.
In planning to assess the evidence produced by this 
evaluation, we have been influenced by the principles 
of realistic evaluation [19] in which the mechanism 
(the intervention) acts in context to produce the out-
come. If there is a single lesson from previous evalu-
ations of attempts to integrate or coordinate care, it 
is that the context in which an intervention is intro-
duced is crucially important to its success or failure. 
So, in this evaluation, we have committed substan-
tial resources to the qualitative evaluation, knowing 
that these analyses will be critical to interpreting the 
results of quantitative analyses. Our approach is to 
understand not only the ‘dose, frequency and effect’ 
but  to  identify  the  way  pilots  learn,  respond  and 
evolve and to take into account the expectations and 
motivations of staff and patients to understand how 
complex and evolving projects might have lessons for 
others seeking to do related things in different con-
texts. Policy makers, professionals, managers, car-
ers and patients are all part of an emergent process. 
We do not expect to measure precisely all effects but   
we do expect to understand the likely scope of ben-
efits and the scale of efforts required, to contribute 
to  the  analysis  of  health  service  interventions  and 
so reduce decision-makers’ uncertainties about inte-
grated care.
This  evaluation  will  produce  a  portfolio  of  evidence 
including  interviews,  surveys,  cost  estimations  and 
service  utilisation  data  aimed  at  strengthening  the   
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Annex 1
Summary of focus of individual Integrated Care Pilot sites
Pilot Main focus (some sites have other objectives also)
Bournemouth and Poole Structured support for people with dementia in the community
Cambridge Support for end of life care in the community; reduction in unnecessary admissions to hospital
Church View Medical Practice Improved support for people with long-term conditions at risk of admission to hospital
Cumbria Improved support for people with long-term conditions at risk of admission to hospital
Durham Dales Providing integrated primary and secondary care service for acutely ill people, improved 
community services, moving specialist services into the community, identification of people at 
risk of fuel poverty
Northamptonshire Integrated  
Care Partnership (NENE)
Improved support for people with long-term conditions at risk of admission to hospital
Newquay Structured support for people with dementia in the community
Norfolk Improved support for people with long-term conditions at risk of admission to hospital
North Tyneside Screening of patients at risk of falls: assessment by multi-disciplinary team
Northumbria Improved support for people with COPD with a history of admissions to hospital
North Cornwall Mental health care
Principia Partners in Health Improved support for people with long-term conditions at risk of admission to hospital. Second 
stream has specific focus on people with COPD
Tameside and Glossop Structured programme of identification and management of people at risk of cardio-vascular 
disease (CVD). Second stream of work for people with established CVD
Torbay Improved discharge planning. Support for GPs from community geriatrician. Improved support 
for people in the community with dementia, COPD and congestive cardiac failure. Falls 
prevention programme
Tower Hamlets Structured care for people with diabetes
Wakefield Integrated Substance Misuse 
Service
Implementation of ‘dashboard’ routinely feeding back performance data for services providing 
care for people with substance misuseInternational Journal of Integrated Care  – Vol. 10, 27 September 2010 – ISSN 1568-4156  – http://www.ijic.org/
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Annex 2
List of ‘ambulatory care sensitive conditions’ (ACSCs) and associated ICD-10 codes (derived from AHRQ [14] and 
Purdy et al. [15]). These are admissions for diagnoses that in principle may be preventable by good quality primary 
care
Ambulatory care sensitive condition ICD-10 code Definition
Alcohol-related disease F10 Mental and behavioural disorders due to use of alcohol
Angina I20 Angina pectoris
Angina I240 Coronary thrombosis not resulting in myocardial infarction
Angina I248 Other forms of acute ischemic heart disease
Angina I249 Acute ischemic heart disease, unspecified
Angina I25 Chronic ischemic heart disease
Angina R072 Precordial pain
Asthma J45 Asthma
Asthma J46 Status asthmaticus
Atrial fibrillation and flutter I471 Supra-ventricular tachycardia
Atrial fibrillation and flutter I479 Paroxysmal tachycardia, unspecified
Atrial fibrillation and flutter I495 Sick sinus syndrome
Atrial fibrillation and flutter I498 Other specified cardiac arrhythmias
Atrial fibrillation and flutter I499 Cardiac arrhythmia, unspecified
Atrial fibrillation and flutter R000 Tachycardia, unspecified
Atrial fibrillation and flutter R002 Palpitations
Atrial fibrillation and flutter R008 Other and unspecified abnormalities of heart beat
Cellulitis I891 Lymphangitis
Cellulitis L010 Impetigo [any organism] [any site]
Cellulitis L011 Impetiginization of other dermatoses
Cellulitis L020 Cutaneous abscess, furuncle, and carbuncle of face
Cellulitis L021 Cutaneous abscess, furuncle, and carbuncle of neck
Cellulitis L022 Cutaneous abscess, furuncle, and carbuncle of trunk
Cellulitis L023 Cutaneous abscess, furuncle, and carbuncle of buttock
Cellulitis L024 Cutaneous abscess, furuncle, and carbuncle of limb
Cellulitis L028 Cutaneous abscess, furuncle, and carbuncle of other sites
Cellulitis L029 Cutaneous abscess, furuncle, and carbuncle, unspecified
Cellulitis L03 Cellulitis
Cellulitis L04 Acute lymphadenitis
Cellulitis L080 Pyoderma
Cellulitis L088 Other specified local infections of skin and subcutaneous tissue
Cellulitis L089 Local infection of skin and subcutaneous tissue, unspecified
Cellulitis L88 Pyoderma gangrenosum
Cellulitis L980 Pyogenic granuloma
Congestive heart failure I110 Hypertensive heart disease with (congestive) heart failure
Congestive heart failure I130 Hypertensive heart and renal disease with (congestive) heart failure
Congestive heart failure I132 Hypertensive heart and renal disease with both (congestive) heart failure and 
renal failure
Congestive heart failure I255 Ischemic cardiomyopathy
Congestive heart failure I50 Heart failure
Congestive heart failure J81 Pulmonary edema
Constipation K590 Constipation
Convulsions and Epilepsy G253 Myoclonus
Convulsions and Epilepsy G40 Epilepsy
Convulsions and Epilepsy G41 Status epilepticus
Convulsions and Epilepsy R56 Convulsions, not elsewhere classified
COPD J40 Bronchitis, not specified as acute or chronic
COPD J41 Simple and mucopurulent chronic bronchitis
COPD J42 Unspecified chronic bronchitis
COPD J43 Emphysema
COPD J44 Other chronic obstructive pulmonary disease
COPD J47 Bronchiectasis
COPD J20 Acute bronchitis
Dehydration and gastroenteritis A020 Salmonella gastroenteritis
Dehydration and gastroenteritis A04 Other bacterial intestinal infections
Dehydration and gastroenteritis A059 Bacterial food-borne intoxication, unspecified
Dehydration and gastroenteritis A072 Cryptosporidiosis
Dehydration and gastroenteritis A080 Rotaviral enteritisThis article is published in a peer reviewed section of the International Journal of Integrated Care   12
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Ambulatory care sensitive condition ICD-10 code Definition
Dehydration and gastroenteritis A081 Acute gastroenteropathy due to Norwalk agent
Dehydration and gastroenteritis A082 Adenoviral enteritis
Dehydration and gastroenteritis A083 Other viral enteritis
Dehydration and gastroenteritis A084 Viral intestinal infection, unspecified
Dehydration and gastroenteritis A085 Other specified intestinal infections
Dehydration and gastroenteritis A09 Diarrhea and gastroenteritis of presumed infectious origin
Dehydration and gastroenteritis E86 Volume depletion
Dehydration and gastroenteritis K520 Gastroenteritis and colitis due to radiation
Dehydration and gastroenteritis K521 Toxic gastroenteritis and colitis
Dehydration and gastroenteritis K522 Allergic and dietetic gastroenteritis and colitis
Dehydration and gastroenteritis K528 Other specified non-infective gastroenteritis and colitis
Dehydration and gastroenteritis K529 Non-infective gastroenteritis and colitis, unspecified
Dementia F00 Dementia in Alzheimer’s disease
Dementia F01 Vascular dementia
Dementia F02 Dementia in other diseases classified elsewhere
Dementia F03 Unclassified dementia
Dementia R54 Senility
Dental conditions A690 Necrotizing ulcerative stomatitis
Dental conditions K02 Dental caries
Dental conditions K03 Other diseases of hard tissues of teeth
Dental conditions K04 Diseases of pulp and periapical tissues
Dental conditions K05 Gingivitis and periodontal diseases
Dental conditions K06 Other disorders of gingiva and edentulous alveolar ridge
Dental conditions K08 Other disorders of teeth and supporting structures
Dental conditions K098 Other cysts of oral region, not elsewhere classified
Dental conditions K099 Cyst of oral region, unspecified
Dental conditions K12 Stomatitis and related lesions
Dental conditions K13 Other diseases of lip and oral mucosa
Diabetes complications E100 Insulin-dependent diabetes mellitus with coma
Diabetes complications E101 Insulin-dependent diabetes mellitus with ketoacidosis
Diabetes complications E102 Insulin-dependent diabetes mellitus with renal complications
Diabetes complications E103 Insulin-dependent diabetes mellitus with ophthalmic comps
Diabetes complications E104 Insulin-dependent diabetes mellitus with neurological comps
Diabetes complications E105 Insulin-dependent diabetes mellitus with periph circ comps
Diabetes complications E106 Insulin-dependent diabetes mellitus with other spec comps
Diabetes complications E107 Insulin-dependent diabetes mellitus with multiple comps
Diabetes complications E108 Insulin-dependent diabetes mellitus with unspec comps
Diabetes complications E110 Non-insulin-dependent diabetes mellitus with coma
Diabetes complications E111 Non-insulin-dependent diabetes mellitus with ketoacidosis
Diabetes complications E112 Non-insulin-dependent diabetes mellitus with renal comps
Diabetes complications E113 Non-insulin-dependent diabetes mellitus with ophthalm comps
Diabetes complications E114 Non-insulin-dependent diabetes mellitus with neuro comps
Diabetes complications E115 Non-insulin-dependent diabetes mellitus with periph circ comp
Diabetes complications E116 Non-insulin-dependent diabetes mellitus with other spec comp
Diabetes complications E117 Non-insulin-dependent diabetes mellitus with multiple comps
Diabetes complications E118 Non-insulin-dependent diabetes mellitus with unspec comps
Diabetes complications E120 Malnutrition-related diabetes mellitus with coma
Diabetes complications E121 Malnutrition-related diabetes mellitus with ketoacidosis
Diabetes complications E122 Malnutrition-related diabetes mellitus with renal comps
Diabetes complications E128 Malnutrition-related diabetes mellitus with unspec comps
Diabetes complications E130 Other specified diabetes mellitus with coma
Diabetes complications E131 Other specified diabetes mellitus with ketoacidosis
Diabetes complications E132 Other specified diabetes mellitus with renal complications
Diabetes complications E133 Other specified diabetes mellitus with ophthalmic comps
Diabetes complications E134 Other specified diabetes mellitus with neurological comps
Diabetes complications E135 Other specified diabetes mellitus with periph circ comps
Diabetes complications E136 Other specified diabetes mellitus with other spec comps
Diabetes complications E137 Other specified diabetes mellitus with multiple comps
Diabetes complications E138 Other specified diabetes mellitus with unspecified comps
Diabetes complications E140 Unspecified diabetes mellitus with coma
Diabetes complications E141 Unspecified diabetes mellitus with ketoacidosis
Diabetes complications E142 Unspecified diabetes mellitus with renal complications
Diabetes complications E143 Unspecified diabetes mellitus with ophthalmic complications
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Ambulatory care sensitive condition ICD-10 code Definition
Diabetes complications E144 Unspecified diabetes mellitus with neurological comps
Diabetes complications E145 Unspecified diabetes mellitus with periph circulatory comps
Diabetes complications E146 Unspecified diabetes mellitus with other specified comps
Diabetes complications E147 Unspecified diabetes mellitus with multiple complications
Diabetes complications E148 Unspecified diabetes mellitus with unspecified complications
Dyspepsia and other stomach function 
disorders
K21 Gastroesophageal reflux disease
Dyspepsia and other stomach function 
disorders
K30 Dyspepsia
Ear, nose and throat infections H66 Suppurative and unspecified otitis media
Ear, nose and throat infections H67 Otitis media in diseases classified elsewhere
Ear, nose and throat infections J02 Acute pharyngitis
Ear, nose and throat infections J03 Acute tonsillitis
Ear, nose and throat infections J040 Acute laryngitis
Ear, nose and throat infections J06 Acute upper respiratory infections of multiple and unspecified sites
Ear, nose and throat infections J312 Chronic pharyngitis
Fractured proximal femur S720 Fracture of neck of femur
Fractured proximal femur S721 Pertrochanteric fracture
Fractured proximal femur S722 Subtrochanteric fracture
Gangrene R02 Gangrene, not elsewhere classified
Hypertension I10 Essential (primary) hypertension
Hypertension I119 Hypertensive heart disease without (congestive) heart failure
Hypertension I129 Hypertensive renal disease without renal failure
Hypertension I139 Hypertensive heart and renal disease, unspecified
Hypokalaemia E876 Hypokalemia
Influenza and pneumonia A481 Legionnaires’ disease
Influenza and pneumonia A70 Chlamydia psittaci infection
Influenza and pneumonia J10 Influenza due to identified influenza virus
Influenza and pneumonia J11 Influenza, virus not identified
Influenza and pneumonia J120 Adenoviral pneumonia
Influenza and pneumonia J121 Respiratory syncytial virus pneumonia
Influenza and pneumonia J122 Parainfluenza virus pneumonia
Influenza and pneumonia J128 Other viral pneumonia
Influenza and pneumonia J129 Viral pneumonia, unspecified
Influenza and pneumonia J13 Pneumonia due to Streptococcus pneumoniae
Influenza and pneumonia J14 Pneumonia due to Hemophilus influenzae
Influenza and pneumonia J153 Pneumonia due to streptococcus, group B
Influenza and pneumonia J154 Pneumonia due to other streptococci
Influenza and pneumonia J157 Pneumonia due to Mycoplasma pneumoniae
Influenza and pneumonia J159 Bacterial pneumonia, unspecified
Influenza and pneumonia J160 Chlamydial pneumonia
Influenza and pneumonia J168 Pneumonia due to other specified infectious organisms
Influenza and pneumonia J18 Pneumonia, organism unspecified
Iron-deficiency anaemia D460 Refractory anemia without sideroblasts, so stated
Iron-deficiency anaemia D461 Refractory anemia with sideroblasts
Iron-deficiency anaemia D463 Refractory anemia with excess of blasts with transformation
Iron-deficiency anaemia D464 Refractory anemia, unspecified
Iron-deficiency anaemia D501 Sideropenic dysphagia
Iron-deficiency anaemia D508 Other iron deficiency anemias
Iron-deficiency anaemia D509 Iron deficiency anemia, unspecified
Iron-deficiency anaemia D510 Vitamin B12 deficiency anemia due to intrinsic factor deficiency
Iron-deficiency anaemia D511 Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with 
proteinuria
Iron-deficiency anaemia D512 Transcobalamin II deficiency
Iron-deficiency anaemia D513 Other dietary vitamin B12 deficiency anemia
Iron-deficiency anaemia D518 Other vitamin B12 deficiency anemias
Iron-deficiency anaemia D520 Dietary folate deficiency anemia
Iron-deficiency anaemia D521 Drug-induced folate deficiency anemia
Iron-deficiency anaemia D528 Other folate deficiency anemias
Iron-deficiency anaemia D529 Folate deficiency anemia, unspecified
Iron-deficiency anaemia D531 Other megaloblastic anemias, not elsewhere classified
Iron-deficiency anaemia D571 Sickle-cell anemia without crisis
Iron-deficiency anaemia D580 Hereditary spherocytosis
Iron-deficiency anaemia D581 Hereditary elliptocytosis
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Ambulatory care sensitive condition ICD-10 code Definition
Iron-deficiency anaemia D590 Drug-induced autoimmune hemolytic anemia
Iron-deficiency anaemia D591 Other autoimmune hemolytic anemias
Iron-deficiency anaemia D592 Drug-induced non-autoimmune hemolytic anemia
Iron-deficiency anaemia D599 Acquired hemolytic anemia, unspecified
Iron-deficiency anaemia D601 Transient acquired pure red cell aplasia
Iron-deficiency anaemia D608 Other acquired pure red cell aplasias
Iron-deficiency anaemia D609 Acquired pure red cell aplasia, unspecified
Iron-deficiency anaemia D610 Constitutional aplastic anemia
Iron-deficiency anaemia D611 Drug-induced aplastic anemia
Iron-deficiency anaemia D640 Hereditary sideroblastic anemia
Iron-deficiency anaemia D641 Secondary sideroblastic anemia due to disease
Iron-deficiency anaemia D642 Secondary sideroblastic anemia due to drugs and toxins
Iron-deficiency anaemia D643 Other sideroblastic anemias
Iron-deficiency anaemia D644 Congenital dyserythropoietic anemia
Iron-deficiency anaemia D648 Other specified anemias
Migraine/acute headache G43 Migraine
Migraine/acute headache G440 Cluster headache syndrome
Migraine/acute headache G441 Vascular headache, not elsewhere classified
Migraine/acute headache G443 Chronic posttraumatic headache
Migraine/acute headache G444 Drug-induced headache, not elsewhere classified
Migraine/acute headache G448 Other specified headache syndromes
Migraine/acute headache R51 Headache
Nutritional deficiency E40 Kwashiorkor
Nutritional deficiency E41 Nutritional marasmus
Nutritional deficiency E42 Marasmic kwashiorkor
Nutritional deficiency E43 Unspecified severe protein-energy malnutrition
Nutritional deficiency E550 Rickets, active
Nutritional deficiency E643 Sequelae of rickets
Other vaccine-preventable diseases A35 Other tetanus
Other vaccine-preventable diseases A36 Diphtheria
Other vaccine-preventable diseases A37 Whooping cough
Other vaccine-preventable diseases A80 Acute poliomyelitis
Other vaccine-preventable diseases B05 Measles
Other vaccine-preventable diseases B06 Rubella [German measles]
Other vaccine-preventable diseases B161 Acute hepatitis B with delta-agent (coinfection) without hepatic coma
Other vaccine-preventable diseases B169 Acute hepatitis B without delta-agent and without hepatic coma
Other vaccine-preventable diseases B180 Chronic viral hepatitis B with delta-agent
Other vaccine-preventable diseases B181 Chronic viral hepatitis B without delta-agent
Other vaccine-preventable diseases B26 Mumps
Other vaccine-preventable diseases G000 Hemophilus meningitis
Other vaccine-preventable diseases M014 Rubella arthritis
Pelvic inflammatory disease N70 Salpingitis and oophoritis
Pelvic inflammatory disease N73 Other female pelvic inflammatory diseases
Pelvic inflammatory disease N74 Female pelvic inflammatory disorders in diseases classified elsewhere
Perforated appendix K350 Acute appendicitis with generalized peritonitis
Perforated appendix K351 Acute appendicitis with peritoneal abscess
Perforated/bleeding ulcer K20 Esophagitis
Perforated/bleeding ulcer K210 Gastroesophageal reflux disease with esophagitis
Perforated/bleeding ulcer K219 Gastroesophageal reflux disease without esophagitis
Perforated/bleeding ulcer K221 Ulcer of esophagus
Perforated/bleeding ulcer K226 Gastroesophageal laceration-hemorrhage syndrome
Perforated/bleeding ulcer K250 Acute with hemorrhage
Perforated/bleeding ulcer K251 Acute with perforation
Perforated/bleeding ulcer K252 Acute with both hemorrhage and perforation
Perforated/bleeding ulcer K254 Chronic or unspecified with hemorrhage
Perforated/bleeding ulcer K255 Chronic or unspecified with perforation
Perforated/bleeding ulcer K256 Chronic or unspecified with both hemorrhage and perforation
Perforated/bleeding ulcer K260 Acute with hemorrhage
Perforated/bleeding ulcer K261 Acute with perforation
Perforated/bleeding ulcer K262 Acute with both hemorrhage and perforation
Perforated/bleeding ulcer K264 Chronic or unspecified with hemorrhage
Perforated/bleeding ulcer K265 Chronic or unspecified with perforation
Perforated/bleeding ulcer K266 Chronic or unspecified with both hemorrhage and perforation
Perforated/bleeding ulcer K270 Acute with hemorrhage
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Ambulatory care sensitive condition ICD-10 code Definition
Perforated/bleeding ulcer K271 Acute with perforation
Perforated/bleeding ulcer K272 Acute with both hemorrhage and perforation
Perforated/bleeding ulcer K274 Chronic or unspecified with hemorrhage
Perforated/bleeding ulcer K275 Chronic or unspecified with perforation
Perforated/bleeding ulcer K276 Chronic or unspecified with both hemorrhage and perforation
Perforated/bleeding ulcer K280 Acute with hemorrhage
Perforated/bleeding ulcer K281 Acute with perforation
Perforated/bleeding ulcer K282 Acute with both hemorrhage and perforation
Perforated/bleeding ulcer K284 Chronic or unspecified with hemorrhage
Perforated/bleeding ulcer K285 Chronic or unspecified with perforation
Perforated/bleeding ulcer K286 Chronic or unspecified with both hemorrhage and perforation
Perforated/bleeding ulcer K920 Hematemesis
Perforated/bleeding ulcer K921 Melena
Perforated/bleeding ulcer K922 Gastrointestinal hemorrhage, unspecified
Peripheral vascular disease I73 Other peripheral vascular diseases
Tuberculosis A15 Respiratory tuberculosis, bacteriologically and histologically confirmed
Tuberculosis A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically
Tuberculosis A17 Tuberculosis of nervous system
Tuberculosis A18 Tuberculosis of other organs
Tuberculosis A19 Miliary tuberculosis
Urinary infection N10 Acute tubulo-interstitial nephritis
Urinary infection N11 Chronic tubulo-interstitial nephritis
Urinary infection N12 Tubulo-interstitial nephritis, not specified as acute or chronic
Urinary infection N136 Pyonephrosis
Urinary infection N151 Renal and perinephric abscess
Urinary infection N159 Renal tubulo-interstitial disease, unspecified
Urinary infection N30 Cystitis
Urinary infection N390 Urinary tract infection, site not specified
The above table contains all conditions and codes listed in Purdy et al. (2009) tables 3 and 4 except the following:
‘Failure to thrive’ and ‘low birth weight’ are excluded as they are purely paediatric conditions. • •
‘Angina’ codes R073, R074, Z034, Z035 are generic chest pain codes which are unlikely to indicate ischaemic  • •
heart disease.
E139 and E149 not included in ‘diabetes complications’ as both codes specify ‘...without complications’. • •
Mental health admissions (with the exception of ‘dementia’) are excludes as they are not relevant to the evalua- • •
tion sites that are collecting admission data. The excluded conditions are ‘deliberate self-harm’, ‘neuroses’ and 
‘schizophrenia’. ‘Dementia’ is relevant to two pilot sites, and so is retained.
‘Stroke’ is excluded because of the substantial change seen in the admission criteria for stroke over the study  • •
period.
O15 is excluded from ‘convulsions and epilepsy’ as the condition—eclampsia (a specific disorder of pregnancy)— • •
is unrelated, except for the common symptom of fits.
There are also some additional codes included: • •
I129, I139, I132 and A082 are introduced by the process of converting the AHRQ codes from ICD-9CM to  • •
ICD-10.
All cystitis codes (N30) are included in ‘urinary tract infection’, supplementing N300, N308 and N309. • •